TGA
Therapeutic Goods (Permissible Ingredients) Determination (No.3) 2026
Listed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 3) 2026 - external site which commenced on 16 October 2026. This determination replaces the previous instrument, the Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2026 - external site.
This instrument is updated frequently and there may be a more recent version of the instrument. Ensure you are accessing the current version of the instrument through the Therapeutic Goods (Permissible Ingredients) Determination page.
A complete list of the 10 changed ingredients is below:
Changed ingredients
| Substance name | Change |
|---|---|
| magnesium L-threonate monohydrate | Addition |
| mitoquinol mesilate | Addition |
| gamma glutamylcysteine | Addition |
| styrene/isoprene/styrene block copolymer | Addition |
| hydrocarbons, C6-C20, polymers, hydrogenated | Addition |
| Bacillus coagulans | Change |
| Bacillus subtilis | Change |
| Akkermansia muciniphila | Change |
| Terminalia ferdinandiana | Change |
| 2-methyl-4-propyl-1,3-oxathiane | Change |
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
